Related Experiment Video
Updated: Feb 12, 2026

Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020
Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease
Meghan Martin1, Brian H Wrotniak1, Mark Hicar1
1Department of Pediatrics, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, United States of America.
Insights
Infants show reduced plasmablast responses, similar in Kawasaki disease (KD) and controls. This suggests an infectious link to KD, but further infant immune studies are needed.
Area of Science:
- Pediatric immunology
- Infectious diseases
- B cell biology
Background:
- Kawasaki disease (KD) is a leading cause of acquired heart disease in children, predominantly affecting infants and toddlers.
- Understanding infant immune responses is crucial for KD research but remains limited.
- Plasmablasts, transitional B cells, are key to adaptive immunity, but their role in infants is understudied.
Purpose of the Study:
- To investigate and compare plasmablast responses in infants and children with Kawasaki disease (KD) versus febrile controls.
- To explore the role of plasmablasts in the immune response during KD in the predominant age group affected.
Main Methods:
- Recruited children with suspected KD or overlapping symptoms from a pediatric emergency room.
- Isolated peripheral blood mononuclear cells and analyzed B cell markers using flow cytometry.
- Compared plasmablast levels in 18 KD subjects and 69 febrile controls.
Main Results:
- Plasmablast numbers and temporal patterns were similar between KD subjects and infectious disease controls.
- Infants in both KD and control groups exhibited diminished plasmablast responses compared to older children.
- A blunted peripheral plasmablast response was observed in infants during this single-time point survey.
Conclusions:
- Similar plasmablast responses in KD and controls suggest a potential infectious etiology for KD.
- Infants demonstrate a generally weaker peripheral plasmablast response, irrespective of KD status.
- Further longitudinal studies on infant plasmablast kinetics are necessary to understand their contribution to immune responses.
Background:
Kawasaki disease (KD), the leading cause of acquired heart disease in children, primarily affects infants and toddlers. Investigations on immune responses during KD are hampered by a limited understanding of normal immune responses in these ages. It's well known that Infants have poorer vaccine responses and difficulty with maintaining prolonged serum immunity, but there are few studies on human infants detailing immune deficiencies. Limited studies propose an inability to maintain life-long bone marrow plasma cells. Plasmablasts are a transitional cell form of B cells that lead to long-term Plasma cells. Plasmablasts levels rise in the peripheral blood after exposure to a foreign antigen. In adult studies, these responses are both temporally and functionally well characterized. To date, there have been few studies on plasmablasts in the predominant age range of KD.
Methods:
Children presenting to an urban pediatric emergency room undergoing laboratory evaluation, who had concern of KD or had fever and symptoms overlapping those of KD, were recruited. Peripheral blood mononuclear cells were isolated and evaluated utilizing flow cytometry with specific B cell markers from 18 KD subjects and 69 febrile controls.
Results:
Plasmablast numbers and temporal formation are similar between infectious disease controls and KD subjects. In both groups, infants have diminished plasmablast responses compared to older children.
Conclusion:
In this single-time point survey, infants have a blunted peripheral plasmablast response. Overall, similar plasmablast responses in KD and controls support an infectious disease relationship to KD. Future time-course studies of plasmablasts in infants are warranted as this phenomenon may contribute to observed immune responses in this age group.
Related Concept Videos
Drug Dosing: Infants and Children
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Responses to Gravity and Touch
Humoral Immune Responses

